Erratum: Comparison of established and novel purity tests for the quality control of heparin by means of a set of 177 heparin samples (Analytical and Bioanalytical Chemistry (DOI 10.1007/s00216-010-4169-7));Comparison of established and novel purity tests for the quality control of heparin by means of a set of 177 heparin samples

Analytical and Bioanalytical Chemistry

Volumn 399, Issue 2, 2011, Pages 605-620

  Alban, Susanne ^a   Lühn, Susanne ^a   Schiemann, Simone ^a   Beyer, Tanja ^b   Norwig, Jochen ^c   Schilling, Claudia ^d   Rädler, Oliver ^d   Wolf, Bernhard ^d   Matz, Magnus ^e   Baumann, Knut ^e   Holzgrabe, Ulrike ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c FEDERAL INSTITUTE FOR DRUGS AND MEDICAL DEVICES   (Germany)

^d Ratiopharm Group   (Germany)

^e TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

ATR IR spectroscopy; Chemometric classification; Coagulation assays; Heparin; OSCS; Purity tests; Raman spectroscopy; Two step aXa assay; Two step fluorescence assay

Indexed keywords

ASSAYS; COAGULATION; FLUORESCENCE; INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PLASMA (HUMAN); POLYSACCHARIDES; QUALITY ASSURANCE; RAMAN SPECTROSCOPY; SPECTROSCOPIC ANALYSIS; SULFUR COMPOUNDS;

ATR-IR SPECTROSCOPY; CHEMOMETRIC CLASSIFICATION; COAGULATION ASSAYS; FLUORESCENCE ASSAY; HEPARIN; OSCS;

QUALITY CONTROL;

OVIS ARIES;

EID: 79251645872     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-010-4317-0     Document Type: Erratum

References (52)

1. FDA, U.S. Food and Drug Administration (2009) Information on Adverse Event Reports and Heparin. http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm112669.htm. Accessed 11 June 2010
2. Royce K FDA failures contribute to spread of contaminated drugs (2008) Worldfocus 17.12.2008 http://worldfocus.org/blog/2008/12/17/fda-failures- contribute-to-spread-of-contaminated-drugs/3287/. Accessed 11 Jun 2010
3. M Guerrini D Beccati Z Shriver A Naggi K Viswanathan A Bisio I Capila JC Lansing S Gulieri B Fraser A Al-Hakim NS Gunay Z Zhang L Robinson L Buhse M Nasr J Woodchock R Langer G Venkataraman RJ Linhardt B Casu G Torri R Sasisekharan 2008 Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events Nat Biotechnol 26 669 675 1:CAS:528: DC%2BD1cXmvVCisrY%3D 10.1038/nbt1407
4. L Liverani G Mascellani F Spelta 2009 Heparins: process-related physico-chemical and compositional characteristics, fingerprints and impurities Thromb Haemost 102 846 853 1:CAS:528:DC%2BD1MXhsFajtr%2FL
5. B Mulloy E Gray TW Barrowcliffe 2000 Characterisation of unfractionated heparin: comparison of materials from the last 50 years Thromb Haemost 84 1052 1056 1:CAS:528:DC%2BD3MXlvFakug%3D%3D
6. I McEwen B Mulloy E Hellwig L Kozerski T Beyer U Holzgrabe A Rodomonte R Wanko JM Spieser 2008 Determination of oversulphated chondroitin sulphate and dermatan sulphate in unfractionated heparin by 1H-NMR. Collaborative study for quantification and analytical determination of LoD Pharmeur Bio 1 31 39
7. T Beyer B Diehl G Randel E Humpfer H Schäfer M Spraul C Schollmayer U Holzgrabe 2008 Quality assessment of unfractionated heparin using 1H nuclear magnetic resonance spectroscopy J Pharm Biomed Anal 48 13 19 1:CAS:528:DC%2BD1cXhtVartrfK 10.1016/j.jpba.2008.06.014
8. P Bigler R Brenneisen 2009 Improved impurity fingerprinting of heparin by high resolution 1H NMR spectroscopy J Pharm Biomed Anal 49 1060 1064 1:CAS:528:DC%2BD1MXjvVyisLk%3D 10.1016/j.jpba.2009.01.017
9. M Guerrini Z Shriver A Bisio A Naggi B Casu R Sasisekharan 2009 The tainted heparin story: an update Thromb Haemost 102 907 911 1:CAS:528: DC%2BD1MXhsFajtrzK
10. M Guerrini Z Shriver A Naggi B Casu RJ Linhardt G Torri R Sasisekharan 2010 Reply to oversulfated chondroitin sulfate is not the sole contaminant in heparin Nat Biotechnol 28 207 211 1:CAS:528:DC%2BC3cXivV2rtbg%3D 10.1038/nbt0310-207
11. I McEwen T Rundlöf M Ek B Hakkarainen G Carlin T Arvidsson 2009 Effect of Ca2+ on the 1H NMR chemical shift of the methyl signal of oversulphated chondroitin sulphate, a contaminant in heparin J Pharm Biomed Anal 49 816 819 1:CAS:528:DC%2BD1MXivVGjurk%3D 10.1016/j.jpba.2008.12.012
12. I McEwen 2010 Broadening of 1H-NMR signals in the spectra of heparin and OSCS by paramagnetic transition metal ions. The use of EDTA to sharpen the signals J Pharm Biomed Anal 51 733 735 1:CAS:528:DC%2BD1MXhtl2jtrzI 10.1016/j.jpba.2009.09.009
13. Z Zhang L Boyangzi J Suwan F Zhang Z Wang H Liu B Mulloy RJ Linhardt 2009 Analysis of pharmaceutical heparins and potential contaminants using 1H-NMR and PAGE J Pharm Sci 98 4017 4026 1:CAS:528:DC%2BD1MXhtF2qtLfP 10.1002/jps.21729
14. Heparin sodium, monograph Stage 2 (2009) US Pharmacopoeia, Rockville http://www.usp.org/USPNF/notices/heparinRB20090828.html
15. Heparin sodium, monograph 0333 (2010) European Pharmacopoeia, Council of Europe, Strasbourg, PA/PH/Exp. 6/T (09) 42 PUB. http://www.edqm.eu/en/What-new- 525.html
16. GW Somsen YH Tak JS Toraño PMJM Jongen GJ de Jong 2009 Determination of oversulfated chondroitin sulfate and dermatan sulfate impurities in heparin by capillary electrophoresis J Chromatogr A 1216 4107 4112 1:CAS:528:DC%2BD1MXkt1SlsLw%3D 10.1016/j.chroma.2009.02.063
17. N Volpi F Maccari RH Linhardt 2009 Quantitative capillary electrophoresis determination of oversulfated chondroitin sulfate as a contaminant in heparin preparations Anal Biochem 388 140 145 1:CAS:528:DC%2BD1MXktFamsbs%3D 10.1016/j.ab.2009.02.012
18. T Wieglos K Havel N Ivanova R Weinberger 2009 Determination of impurities in heparin by capillary electrophoresis using high molarity phosphate buffers J Pharm Biomed Anal 49 319 326 10.1016/j.jpba.2008.11.034
19. ML Trehy JC Reepmeyer RE Kolinski BJ Westenberger LF Buhse 2009 Analysis of heparin sodium by SAX/HPLC for contaminants and impurities J Pharm Biomed Anal 49 670 673 1:CAS:528:DC%2BD1MXivVGjtr8%3D 10.1016/j.jpba.2008.12.013
20. R Domanig W Jöbstl S Gruber T Freudemann 2009 One-dimensional cellulose acetate plate electrophoresis-a feasible method for analysis of dermatan sulfate and other glycosaminoglycan impurities in pharacetuical heparin J Pharm Biomed Anal 49 151 155 1:CAS:528:DC%2BD1MXhtFCjtLg%3D 10.1016/j.jpba.2008.10.017
21. S Alban S Lühn 2008 Prothrombin time for detection of contaminated heparins N Engl J Med 359 2732 2734 1:CAS:528:DC%2BD1cXhsFaqtLjM 10.1056/NEJMc0807070
22. J Norwig T Beyer D Brinz U Holzgrabe M Diller D Manns 2009 Prediction of the oversulphated chondroitin sulphate contamination of unfractionated heparin by ATR-IR spectroscopy Pharmeur Sci Notes 2009 17 24 1:STN:280: DC%2BD1M7pvFyhsA%3D%3D
23. S Bairstow J McKee M Nordhaus R Johnson 2009 Identification of a simple and sensitive microplate method for the detection of oversulfated chondroitin sulfate in heparin productions Anal Biochem 388 317 321 1:CAS:528: DC%2BD1MXkvVWns7w%3D 10.1016/j.ab.2009.03.009
24. M Guerrini Z Zhang Z Shriver A Naggi S Masuko R Langer B Casu RJ Linhardt G Torri R Sasisekharan 2009 Orthogonal analytical approaches to detect potential contaminants in heparin Proc Natl Acad Sci 106 16956 16961 1:CAS:528:DC%2BD1MXhtlaks7fI 10.1073/pnas.0906861106
25. J Sitkowski E Bednarek W Bocian L Kozerski 2008 Assessment of oversulfated chondroitin sulfate in low molecular weight and unfractioned heparins diffusion ordered nuclear magnetic resonance spectroscopy method J Med Chem 51 7663 76665 1:CAS:528:DC%2BD1cXhsVKlu7rF 10.1021/jm801198b
26. N Hashii N Kawasaki S Itoh Y Qin N Fujita T Hattori K Miyata A Bando Y Sekimoto T Hama M Kashimura M Tatsumi K Mabuchi H Namekawa T Sakai M Hirose S Bobashi H Shimahasi S Koyama SO Herr K Kawai H Yoden T Yamaguchi 2010 Heparin identification test and purity test for OSCS in heparin sodium and heparin calcium by weak anion-exchange high-performance liquid chromatography Biologicals 10.1016/j.biologicals.2010.04.002
27. J Pan Y Qian X Zhou A Pazandak SB Frazier P Weiser H Lu L Zhang 2010 Oversulfated chondroitin sulfate is not the sole contaminant in heparin Nat Biotechnol 28 203 207 1:CAS:528:DC%2BC3cXivV2rsbc%3D 10.1038/nbt0310-203
28. Lühn S, Schiemann S, Alban S (2010) Simple fluorescence assay for quantification of OSCS in heparin. Anal Bioanal Chem. Online First (16.06.10): doi: 10.1007/s00216-010-3867-5
29. GA Neville F Mori KR Holme AS Perlin 1989 Monitoring the purity of pharmaceutical heparin preparations by high-field 1H-NMR magnetic resonance spectroscopy J Pharm Sci 78 101 104 1:CAS:528:DyaL1MXht1WmsLs%3D 10.1002/jps.2600780205
30. RJ Linhardt NS Gunay 1999 Production and chemical processing of low molecular weight heparins Semin Thromb Hemost 25 5 16 1:CAS:528: DyaK1MXntlart74%3D 10.1055/s-2007-996417
31. T Beyer M Matz D Brinz O Rädler B Wolf J Norwig K Baumann S Alban U Holzgrabe 2010 Composition of OSCS-contaminated heparin occuring in 2008 in Batches on the German market Eur J Pharm Sci 40 297 304 1:CAS:528: DC%2BC3cXmslOhtb8%3D 10.1016/j.ejps.2010.04.002
32. W Sun H Bandmann T Schrader 2007 Chemistry 13 7701 7707 1:CAS:528:DC%2BD2sXhtFWktrzE 10.1002/chem.200700677
33. Infrared Absorption Spectrophotometry, general method 2.2.24 (2008), European Pharmacopoeia, Council of Europe, Strasbourg
34. U Schmid P Rösch M Krause M Harz J Popp K Baumann 2009 Gaussian mixture discriminant analysis for the single-cell differentiation of bacteria using micro-Raman spectroscopy Chemom Intell Lab Syst 96 159 171 1:CAS:528:DC%2BD1MXkslKksro%3D 10.1016/j.chemolab.2009.01.008
35. MacLachlan GJ (1991) Discriminant analysis and pattern recognition. Wiley, New York
36. Jolliffe IT (2002) Principal component analysis, 2nd edn. Springer, New York
37. Efron B, Tibshirani R (1993) An introduction to the bootstrap. Chapman & Hall/CRC, Boca Raton
38. R Wehrens H Putter LMC Buydens 2000 The bootstrap. A tutorial Chemom Intell Lab Syst 54 35 52 1:CAS:528:DC%2BD3MXisVOrt7w%3D 10.1016/S0169-7439(00) 00102-7
39. Breiman L (1996) Out-of-bag estimation, Technical Report. Department of Statistics, University of California, USA
40. DH Wolpert WG Mcready 1999 An efficient method to estimate bagging's generalization error Mach Learn 35 41 55 10.1023/A:1007519102914
41. L Breiman 2001 Random forests Mach Learn 45 5 32 10.1023/A:1010933404324
42. V Svetnik A Liaw C Tong JC Culberson RP Sheridan BP Feuston 2003 Random forest: a classification and regression tool for compound classification and QSAR modeling J Chem Inf Comput Sci 43 1947 1958 1:CAS:528:DC%2BD3sXos1Wiu7s%3D
43. KR Holme A Perlin 1989 Nuclear magnetic resonance spectra of heparin in admixture with dermatan sulfate and other glycosaminoglycans. 2-D spectra of the chondroitin sulfates Carbohydr Res 186 301 312 1:CAS:528:DyaL1MXhsFSisLk%3D 10.1016/0008-6215(89)84044-3
44. DA Keire DJ Mans H Ye RE Kolinski LF Buhse 2010 Assay of possible economically motivated additives or native impurities levels in heparin by 1H NMR, SAX-HPLC, and anticoagulation time approaches J Pharm Biomed Anal 52 656 664 1:CAS:528:DC%2BC3cXksVamsrs%3D 10.1016/j.jpba.2010.02.019
45. Rabenstein DL, Keire DA (1991) Quantitative chemical analysis by NMR. In: Popov AI, Hallenga K (eds) Modern NMR techniques and their application in chemistry. Marcel Dekker, New York, pp 323-369
46. Chandola V, Banerjee A, Kumar V (2009) Anomaly detection: a survey. ACM Comput Surv 41, Article 15
47. TR Rudd MA Skidmore SE Guimond C Cosentino G Torri DG Fernig RM Lauder M Guerrini EA Yates 2009 Glycosaminoglycan origin and structure revealed by multivariate analysis of NMR and CD spectra Glycobiology 19 52 67 1:CAS:528:DC%2BD1cXhsV2rs77F 10.1093/glycob/cwn103
48. B Li J Suwan JG Martin F Zhang Z Zhang D Hoppensteadt M Clark J Fareed RJ Linhardt 2009 Oversulfated chondroitin sulfate interaction with heparin-binding proteins: new insights into adverse reactions from contaminated heparins Biochem Pharmacol 78 292 300 1:CAS:528:DC%2BD1MXms1WgsLs%3D 10.1016/j.bcp.2009. 04.012
49. S Schiemann S Lühn S Alban 2010 A novel method for the simultaneous detection of various contaminants in heparins Hamostaseologie 30 A111
50. A Greinacher TE Warkentin 2008 Contaminated heparin N Engl J Med 359 1291 1293 1:CAS:528:DC%2BD1cXhtFGisLfI 10.1056/NEJMc081387
51. S Lühn T Schrader W Sun S Alban 2010 Development and evaluation of a fluorescence microplate assay for quantification of heparins and other sulfated carbohydrates J Pharm Biomed Anal 52 1 8 10.1016/j.jpba.2009.12.014
52. Alban S, Lühn S (2009) Prothrombin time as a simple screening method to identify heparins contaminated with OSCS and similar compounds. J Thromb Haemost 7(Suppl 2):PP-TH-193